Vidipha Central Pharmaceutical JSC (HOSE:VDP)

Vietnam flag Vietnam · Delayed Price · Currency is VND
50,300
-3,600 (-6.68%)
At close: Jun 11, 2026
Market Cap1.11T +43.9%
Revenue (ttm)971.25B +4.3%
Net Income61.59B -11.2%
EPS2,788.97
Shares Out 22.08M
PE Ratio18.04
Forward PEn/a
Dividend2,500.00 (4.97%)
Ex-Dividend Daten/a
Volume467
Open50,300
Previous Close53,900
Day's Range50,300 - 50,300
52-Week Range34,500 - 60,500
Beta-0.17
Analystsn/a
Price Targetn/a
Earnings DateJul 17, 2026

About HOSE:VDP

Vidipha Central Pharmaceutical Joint Stock Company produces and sells pharmaceutical products in Vietnam. It offers analgesics, antipyretics, gastrointestinal agents, antidiabetic agents, antibiotics, antivirals, antifungals, antihistamines, anti-allergic agents, respiratory agents, cardiovascular, neurological, antihypertensive agents, diuretics, vitamins, minerals, antiseptics, and others. The company also engages in the hotel and real estate businesses; and provision of drug storage and testing, and technology transfer consulting services. I... [Read more]

Industry Pharmaceutical Preparations
Founded 2003
Employees 469
Stock Exchange Ho Chi Minh Stock Exchange
Ticker Symbol VDP
Full Company Profile

Financial Performance

In 2025, HOSE:VDP's revenue was 985.64 billion, an increase of 5.47% compared to the previous year's 934.49 billion. Earnings were 63.81 billion, a decrease of -11.16%.

Financial Statements